Share on StockTwits

Investment Analysts’ ratings reiterations for Thursday, September 4th:

Apple (NASDAQ:AAPL) had its buy rating reaffirmed by analysts at Cantor Fitzgerald.

Ambev SA (NASDAQ:ABEV) had its overweight rating reiterated by analysts at Morgan Stanley. They currently have a $8.30 target price on the stock, down from their previous target price of $8.40. The analysts wrote, “We see favorable risk-reward, despite near-term uncertainty regarding excise taxes in Brazil, as the stock is pricing in moderated expectations for future growth, which may not be the case for other consumer stocks. We also think ABEV’s dividend stream should be strong and sustainable.”

Actavis plc (NYSE:ACT) had its overweight rating reissued by analysts at Morgan Stanley. The firm currently has a $266.00 price target on the stock, up from their previous price target of $246.00. The analysts wrote, “We believe more large-cap Value and GARP fund managers will come to appreciate Actavis. ACT is now hitting mega-cap radar screens since its mkt cap has stepped up from $18B in Aug. ’13 to $60B today. We think ACT is an attractive alternative to large-cap pharma because it trades at a discount on 2015E P/E (14x vs. 17x) and senior mgmt. are astute leaders with a sense of urgency to create extra value via M&A.”

Analog Devices (NYSE:ADI) had its buy rating reiterated by analysts at Argus. The firm currently has a $50.25 target price on the stock, down from their previous target price of $65.00.

Baidu Inc (NASDAQ:BIDU) had its positive rating reaffirmed by analysts at Morgan Stanley. The analysts wrote, “Baidu highlighted its new mobile initiatives including Baidu Connect, rich media search, and the development of artificial intelligence. While Baidu will continue to invest aggressively in the near-term, we expect improving mobile monetization should bring operating leverage. Reiterate OW.”

Burlington Stores (NASDAQ:BURL) had its overweight rating reissued by analysts at Morgan Stanley. The firm currently has a $37.00 price target on the stock, up from their previous price target of $35.00. The analysts wrote, “BURL could deliver modest EPS upside, especially if margins outperform conservative guidance, but we don’t expect a material move over earnings. Debt refinancing now appears fully priced in. The stock has substantially outperformed since an early 2014 pullback and remains our top small cap idea.”

Cerner (NASDAQ:CERN) had its overweight rating reiterated by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $67.00 price target on the stock.

Delta Air Lines (NYSE:DAL) had its buy rating reiterated by analysts at CRT Capital.

Google (NASDAQ:GOOGL) had its outperform rating reiterated by analysts at Credit Suisse. They currently have a $589.52 price target on the stock, down from their previous price target of $745.00.

ITC Holdings Corp. (NYSE:ITC) had its overweight rating reiterated by analysts at Wunderlich. They currently have a $41.00 price target on the stock, up from their previous price target of $39.00. The analysts wrote, “Ahead of a competitor conference ITC hosted a dinner that we believe was supportive of our OW-rating. The key takeaways were: 1) Confidence in ROEs having only modest downside based on recent FERC actions and updated calculations of return ranges; 2) Comfort with well-above peer growth targets laid out at the last analyst day; 3) Expectations for federal policy to remain constructive around transmission build out and return levels,albeit with some uncertainty due to changing leadership;and 4) Openness to considering REIT formation at the right time.”

L Brands (NYSE:LB) had its buy rating reaffirmed by analysts at Stifel Nicolaus.

Paycom Software (NYSE:PAYC) had its overweight rating reissued by analysts at Barclays. They currently have a $23.00 price target on the stock, up from their previous price target of $22.00.

PVH Corp (NYSE:PVH) had its equal weight rating reiterated by analysts at Morgan Stanley.

Splunk (NASDAQ:SPLK) had its equal weight rating reiterated by analysts at Barclays. They currently have a $63.00 target price on the stock, up from their previous target price of $52.00.

Walgreen Company (NYSE:WAG) had its neutral rating reaffirmed by analysts at ISI Group.

Workday (NASDAQ:WDAY) had its equal weight rating reissued by analysts at Barclays. Barclays currently has a $94.00 price target on the stock, up from their previous price target of $89.00.

Zoetis (NYSE:ZTS) had its positive rating reiterated by analysts at Bank of America. The analysts wrote, “We are boosting our PO to $40 (from $36) on even greater conviction in our near term view on the heels of encouraging intra-quarter news flow that should bolster enthusiasm for the shares. We believe ZTS should trade more aligned with its peer group of animal health products companies. Our new PO implies 2015E P/E and EV/EBITDA multiples of 22.8x and 15.2x and is supported by our DCF valuation. While ZTS will face a difficult comp in the US (vs. US organic revenue growth of +10% in 3Q13), recent news of a new swine vaccine for PEDv (see note), accelerating QTD hospital same store sales for VCA (see note), and the building opportunity from other ongoing product launches (Georgia 08 vaccine full licensure and Engain/Actogain) should be additive, setting the stage for accelerated growth next year in the US, its largest geographic segment (40% of revenues), particularly when Apoquel, a potential blockbuster drug for atopic dermatitis in dogs, is fully ramped next year.”

Receive News & Ratings for Apple Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apple Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.